Characteristics of patients and controls
| Variable Continuous, median (range) Categorical, n (%) . | Patients with BIA-ALCL (n = 13) . | Controls (n = 39) . |
|---|---|---|
| Age BC surgery, matched variable, y | 44 (37-66) | 44 (36-68) |
| Follow-up, median (IQR), mo | 190 (157-224) | 203 (105-206) |
| BRCA1/2 mutations | 5 (38.5) | 3 (7.8) |
| Bilateral implants | 12 (92) | 28 (72) |
| Previous chemotherapy | 7 (54) | 25 (64) |
| Previous breast RT | 2 (15) | 11 (28) |
| Infiltrating carcinoma | 7 (53) | 30 (77) |
| Ductal vs lobular | 10 (77) | 32 (82) |
| Variable Continuous, median (range) Categorical, n (%) . | Patients with BIA-ALCL (n = 13) . | Controls (n = 39) . |
|---|---|---|
| Age BC surgery, matched variable, y | 44 (37-66) | 44 (36-68) |
| Follow-up, median (IQR), mo | 190 (157-224) | 203 (105-206) |
| BRCA1/2 mutations | 5 (38.5) | 3 (7.8) |
| Bilateral implants | 12 (92) | 28 (72) |
| Previous chemotherapy | 7 (54) | 25 (64) |
| Previous breast RT | 2 (15) | 11 (28) |
| Infiltrating carcinoma | 7 (53) | 30 (77) |
| Ductal vs lobular | 10 (77) | 32 (82) |